Navigation Links
McAdams DeMarco Awarded $100,000 as First Arthritis-Aging Collaborative Researcher

Long Beach, CA and New York, NY (PRWEB) May 07, 2013

Mara McAdams DeMarco, Ph.D. of Johns Hopkins Medical Institutions in Maryland was awarded $100,000 to pursue her research on the risk factors and consequences of gout, a form of arthritis, in older adults. The Arthritis National Research Foundation (ANRF) and the American Federation for Aging Research (AFAR) jointly funded her work in their first-time collaboration of the Arthritis and Aging Research Grant.

Every year ANRF and AFAR award grants to early-stage investigators who are carrying out new and innovative research methods in arthritis and aging, respectively. This award is the first grant funded through a collaboration of ANRF and AFAR.

“This grant studying gout, a problem that afflicts more than three million Americans, fits perfectly into the mission of both organizations,” said ANRF Executive Director Helene Belisle. “The Arthritis National Research Foundation is delighted to pool its resources with AFAR to further research in arthritis and aging,”

Gout is a painful and potentially disabling form of arthritis that has been around since ancient times. The first symptoms are usually intense episodes of painful swelling in single joints, most often in the feet. Gout is an enormous public health problem in the older adults, yet the impact of the disease in the older adults has not been the subject of quality, targeted analysis. Dr. McAdams DeMarco will attempt to answer many important questions, such as whether gout is more disabling in older adults than in younger individuals.

Both nonprofit organizations view research as critical for new information that will ultimately benefit patients. This collaboration reinforces their respective approaches for funding research and ensures that only the best up-and-coming scientists receive support.

“AFAR’s collaboration with ANRF has identified a talented researcher whose work promises to illuminate an important intersection between aging biology and arthritis,” says Stephanie Lederman, EdM, Executive Director of AFAR.

Dr. McAdams DeMarco chose gout as her research topic because of its prevalence, rich history, and because she worked closely with the Department of Epidemiology and Division of Rheumatology at Johns Hopkins to develop her doctoral dissertation on gout. She feels confident that, with her extensive knowledge of the disease, she is well equipped to move the research forward in this area.

“This grant is the perfect opportunity for me to pursue this research interest and will help with my career development,” she said. “My goal is to apply the epidemiology of aging research methods to the understudied population of older adults with gout.”

Dr. McAdams DeMarco completed her doctoral degree in 2012 at Johns Hopkins University and has been a faculty instructor at Johns Hopkins for almost two years. She is well supported by the institution and positioned to succeed with her innovative research on gout.

“This is a unique and potentially high impact study,” added Belisle. “The funding priorities of ANRF and AFAR are so closely aligned and Dr. McAdams DeMarco is an outstanding representative for our first collaborative grant in arthritis and aging research.”

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Scientist awarded $1 million grant to develop tools for hepatitis C treatment discovery
2. $9 million grant awarded to UH to study, treat learning disabilities
3. Kessler Foundation scientist awarded $554,000 for multiple sclerosis employment research
4. Moffitt researcher awarded GE grant to develop tool to detect breast cancer metastasis genetic risks
5. Grant awarded to help improve problem-solving skills for deaf and hard-of-hearing students
6. Southeast program to fight diabetes awarded nearly $10 million by HHS
7. Clemson professor awarded nearly $600,000 4-year grant to study language of plants
8. 29 Johns Hopkins stem cell researchers awarded funding
9. Einstein awarded $6 million grant to develop new TB vaccine against drug-resistant strains
10. FirstVitals Health and Wellness, Inc. awarded $4 Million CMS Innovation Grant for Unique Telehealth Diabetes Progam Focused on Glycemic Control and Prevention of Diabetic Foot Complications
11. EMBO Gold Medal 2012 awarded to Jiri Friml
Post Your Comments:
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
(Date:6/24/2016)... New York, NY (PRWEB) , ... June 24, ... ... lifestyle publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as ... believes that “the most beautiful women in the world, and the most handsome ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC ... by obtaining investment capital for emerging technology companies. SCP has delivered investment ... resulted in more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... ... Venture Construction Group (VCG) sponsors Luke’s Wings 5th ... Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event raised ... have been wounded in battle and their families. Venture Construction Group is a 2016 ...
(Date:6/24/2016)... Gilbert, Arizona (PRWEB) , ... June 24, 2016 ... ... Gilbert-based practice, is supporting the upcoming 2016 Miss Arizona pageant as its official ... primarily serves Scottsdale, Tempe, Mesa, and Chandler, Arizona. , Dr. Olson says ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June ... -based mobile pulmonary function testing company, is now able to ... devices developed by ndd Medical Technologies , Inc. ... done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ... , can get any needed testing done in the comfort of ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
Breaking Medicine Technology: